A practical reference on GHRH analog: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-12-09. Anything still debated is marked as such rather than presented as settled.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
Binding of tesamorelin to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and the release of growth hormone into circulation. Because the peptide acts upstream of the growth hormone axis, its effects are partly mediated by hepatic insulin-like growth factor 1 (IGF-1) production. The pulsatile character of endogenous growth hormone secretion is preserved rather than replaced. Whether amplified signaling produces effects beyond those of native GHRH remains an area of ongoing investigation.
Identity and purity are assessed with reversed-phase high-performance liquid chromatography, which separates the peptide from truncated or oxidized forms. Mass spectrometry confirms the expected molecular weight, and peptide mapping after enzymatic digestion verifies the amino acid sequence. Water content is measured because residual moisture affects stability, and tests for aggregates or particulates are standard for injectable peptides. Circular dichroism can indicate whether the molecule has adopted an unexpected secondary structure in solution.
Research supply is often accompanied by a certificate of analysis listing chromatographic purity, mass confirmation, and storage conditions. Laboratories compare that document with an independent test when material is intended for bench work, since certificates describe a batch rather than an individual vial. Published studies usually state the source and purity of the peptide because small differences in purity can shift measured activity. Full analytical validation is rarely reported, which leaves batch-to-batch comparability an open question.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | GHRH receptor agonist |
| Residue count | 44 amino acids | N-terminal trans-3-hexenoyl group |
| Approximate mass | About 5.1 kDa | Derived from the peptide sequence |
| Primary target | Pituitary GHRH receptor | Somatotroph cells of the anterior pituitary |
| Downstream marker | IGF-1 | Measured indirectly in circulation |
The peptide is synthesized chemically rather than extracted from biological sources. Solid-phase synthesis builds the chain from the C-terminus toward the N-terminus, after which the hexenoyl group is attached. Purity is typically assessed by high-performance liquid chromatography, and identity is confirmed by mass spectrometry. Regulatory review of the finished product focuses on these analytical controls, since small deviations in sequence or modification can change biological activity. Questions about long-term effects on the pituitary axis remain areas of continued investigation.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone (GHRH) family. Its sequence corresponds to the fully active 44-amino-acid form of human GHRH, with a single structural modification: the addition of a trans-3-hexenoyl group at the N-terminus. That modification is not found in the naturally occurring hormone and was introduced deliberately during development to improve stability against enzymatic degradation. The compound is therefore best described as a stabilized analogue rather than a naturally occurring peptide.
The native hormone is produced in the hypothalamus and acts on the anterior pituitary. Binding of GHRH to its receptor stimulates synthesis and release of growth hormone into circulation. Because the analogue retains the receptor-binding region of the parent sequence, it engages the same receptor and triggers the same downstream signaling. The result is increased growth hormone secretion from pituitary cells, which in turn influences hepatic production of insulin-like growth factor 1. This axis is the basis for the compound's measured biological effects.
Identity and purity are assessed by reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities. Mass spectrometry, often coupled to liquid chromatography, confirms molecular mass and detects chemical modifications. Peptide mapping and amino acid analysis can verify sequence integrity. Water content is measured by Karl Fischer titration, and residual solvents may be checked by gas chromatography. These methods together support batch-to-batch consistency and routine quality control.
Lyophilized tesamorelin is generally stored refrigerated at temperatures between 2 and 8 degrees Celsius. The solid form is comparatively stable when kept dry and protected from light. Moisture uptake can promote aggregation and degradation, so sealed containers with desiccant are common. Researchers typically avoid repeated temperature cycling, which may stress the peptide. Documentation accompanying reference materials usually specifies a shelf life under these conditions.
Glutamate is used at the great majority of fast excitatory synapses in the brain and spinal cord. It is also used at most synapses that are "modifiable", i.e. capable of increasing or decreasing in strength. Modifiable synapses are thought to be the main memory-storage elements in the brain. Excessive glutamate release can overstimulate the brain and lead to excitotoxicity causing cell death resulting in seizures or strokes. Excitotoxicity has been implicated in certain chronic diseases including ischemic stroke, epilepsy, amyotrophic lateral sclerosis, Alzheimer's disease, Huntington disease, and Parkinson's disease. GABA is used at the great majority of fast inhibitory synapses in virtually every part of the brain. Many sedative/tranquilizing drugs act by enhancing the effects of GABA. Glycine is the primary inhibitory neurotransmitter in the spinal cord. Acetylcholine was the first neurotransmitter discovered in the peripheral and central nervous systems. It activates skeletal muscles in the somatic nervous system and may either excite or inhibit internal organs in the autonomic system. It is the main neurotransmitter at the neuromuscular junction connecting motor nerves to muscles. The paralytic arrow-poison curare acts by blocking transmission at these synapses. Acetylcholine also operates in many regions of the brain as neuromodulatory, but uses different types of receptors, including nicotinic and muscarinic receptors. Dopamine has a number of important functions in the brain. This includes critical role in the reward system, motivation and emotional arousal.
== References == Charpin, Dominique (2010). Writing, Law, and Kingship in Old Babylonian Mesopotamia. University of Chicago Press. ISBN 978-0-226-10159-0. Charpin, Dominique (2023). "Old Babylonian Law and Justice according to Letters and Legal Documents". In Démare-Lafont, Sophie; Fleming, Daniel E. (eds.). Judicial Decisions in the Ancient Near East. SBL Press. pp. 103–222. doi:10.2307/jj.8784672. ISBN 978-1-62837-486-5. Harris, Rivkah (1969). "Notes on the Babylonian Cloister and Hearth: A Review Article". Orientalia. 38 (1): 133–145. ISSN 0030-5367. JSTOR 43079057. Harris, Rivkah (1976). "On Kinship and Inheritance in Old Babylonian Sippar". Iraq. 38 (2): 129–132. doi:10.2307/4200036. ISSN 0021-0889. Jacquet, Antoine (2013). "Family Archives in Mesopotamia during the Old Babylonian Period". In Faraguna, Michele (ed.). Archives and archival documents in ancient societies: Legal Documents in Ancient Societies IV: Trieste 30 September-1 October 2011. Edizioni Università di Trieste. pp. 63–85. ISBN 978-88-8303-460-2. De Graef, Katrien (2016). "Cherchez la femme! The Economic Role of Women in Old Babylonian Sippar". In Lion, Brigitte; Michel, Cécile (eds.). The Role of Women in Work and Society in the Ancient Near East. De Gruyter. pp. 270–295. doi:10.1515/9781614519089-016. ISBN 978-1-61451-908-9.
May 21, 1992: Decree concerning the responsibilities of the Secretary of State for Women's Rights and Consumer Affairs. July 22, 1992: Law reforming the provisions of the Penal Code relating to the repression of crimes and offenses against persons. November 2, 1992: Law concerning abuse of authority in sexual matters in work relationships and amending the Labour Code and the Code of Criminal Procedure. January 8, 1992: Law amending the Civil Code concerning civil status, family, and children's rights, and establishing the family affairs judge. January 27, 1993: Law concerning various social measures, notably establishing the offense of obstructing abortion and decriminalizing self-induced abortion. April 8, 1993: Decree concerning the responsibilities of the Minister of State, Minister of Social Affairs, Health, and the City. July 22, 1993: Law reforming nationality law. August 2, 1993: Law concerning the control of immigration and the conditions of entry, reception, and residence of foreigners in France. April 21, 1994: Discussion on the possibility of quotas and potential gender parity in the exercise of responsibilities, particularly political ones. July 15, 1994: Law concerning the family. July 29, 1994: Law concerning respect for the human body. July 29, 1994: Law concerning the donation and use of elements and products of the human body, medically assisted procreation, and prenatal diagnosis. June 1, 1995: Decree concerning the responsibilities of the Minister for Intergenerational Solidarity. October 18, 1995: Creation of the Observatory for Gender Parity.
== Bibliography == K.F. Warner, "Boning Lamb Cuts", Leaflet 74, U.S. Department of Agriculture, Bureau of Animal Industry, June 1931. full text. Bob Kennard, "Much ado about mutton". Ludlow: Merlin Unwin, 2014.
Sources: en.wikipedia.org
==== Puberty ==== Leptin along with kisspeptin controls the onset of puberty. High levels of leptin, as usually observed in obese females, can trigger neuroendocrine cascade resulting in early menarche. This may eventually lead to shorter stature as oestrogen secretion starts during menarche and causes early closure of epiphyses.
== History == Interchim was founded by Boch Jean (formerly chemical engineer at Rhone-Poulenc) and Boch Colette in 1970. Their initial activity started with distribution of fine chemicals, then chromatography and Biology. Production was developed as well, in each fields. Affiliate companies were created for production and commercial activities in France, UK (2003), USA (2007) and Instrumentation business (2010). Interchim has now major activity in fine chromatography, fine chemistry and bio-analysis. Leadership in analytical sciences is based on distribution from leading groups (Agilent, Perkin Elmer, Jackson Immunoresearch, Novus, Radleys...), collaborations and proprietary innovative products.
=== 2020 census === As of the 2020 census, Albany had a population of 56,472. The median age was 37.8 years, 36.5 for males and 39.0 for females. 22.3% of residents were under the age of 18 and 18.0% were 65 years of age or older. The gender makeup was 48.7% male and 51.3% female, which corresponds to 94.9 males for every 100 females overall and 92.2 males for every 100 females age 18 and over. 99.8% of residents lived in urban areas, while 0.2% lived in rural areas. There were 22,157 households in Albany, of which 30.0% had children under the age of 18 living in them. Of all households, 46.2% were married-couple households, 17.4% were households with a male householder and no spouse or partner present, and 27.1% were households with a female householder and no spouse or partner present. About 26.7% of all households were made up of individuals and 12.5% had someone living alone who was 65 years of age or older. There were 23,105 housing units, of which 4.1% were vacant. Among occupied housing units, 58.7% were owner-occupied and 41.3% were renter-occupied. The homeowner vacancy rate was 0.9% and the rental vacancy rate was 4.7%. The racial makeup of the city was 79.5% White, 0.8% African American, 1.4% American Indian or Alaska Native, 1.8% Asian, 0.3% Native Hawaiian or Pacific Islander, 5.3% from other races, and 10.9% from two or more races; Hispanic or Latino residents of any race were 14.1% of the population.
At the second trial, the defence called eight medical experts, all university professors, who testified that Sunny's two comas had not been caused by insulin, but by a combination of ingested (not injected) drugs, alcohol, and chronic health conditions. The experts were John Caronna (chairman of neurology, Cornell); Leo Dal Cortivo (former president, U.S. Toxicology Association); Ralph DeFronzo (medicine, Yale University); Kurt Dubowski (forensic pathology, University of Oklahoma); Daniel Foster (medicine, University of Texas Southwestern); Daniel Furst (medicine, University of Iowa); Harold Lebovitz (director of clinical research, State University of New York); Vincent Marks (clinical biochemistry, Surrey, vice-president Royal College of Pathologists and president, Association of Clinical Biochemistry); and Arthur Rubinstein (medicine, University of Chicago). Cortivo testified that the hypodermic needle tainted with insulin on the outside (but not inside) would have been dipped in insulin but not injected; injecting it through flesh would have wiped it clean. Evidence also showed that Sunny's hospital admission three weeks before her final coma showed she had ingested at least 73 aspirin tablets, a quantity that could only have been self-administered, and which indicated her state of mind. Dershowitz, in his book Taking the Stand, writes about von Bülow's dinner party after he was found not guilty at his trial.
=== "Guttergate" === On Friday 24 August 2007, the Seven Network broadcast details obtained from players' confidential medical records on its nightly news program. It allegedly purchased these details for $3,000 from a woman who found them in a gutter outside a medical clinic in Melbourne – leading to the nickname "Guttergate" for the incident. The network said that these records contained details of illicit, non-performance-enhancing drug-taking by players at a particular club in the AFL. The name of the club involved was revealed by Seven on air, but not the names of the players. Seven had promised to reveal the names of the players before the end of the program, but since anonymity was guaranteed by the AFL's three-strikes policy, the AFL obtained a court injunction from the Supreme Court of Victoria to suppress the release of the names – this injunction continues to prevent the publication of any part of the records, including any subsequent publication of the name of the club. At first, Seven vigorously defended its broadcast and stated that it had done so only for the purpose of highlighting the issue of drugs in sport. It challenged the injunction, then faced a backlash both from the AFL and the AFL players themselves. As a result, the players boycotted Seven, refusing to answer any questions posed by its journalists. Seven was not invited to (and, had it still arrived, would have been actively denied entry to) an AFL Players Association (AFLPA) press conference.
Sources: en.wikipedia.org
=== Available forms === Minoxidil is available in the form of oral tablets, topical solution, topical foam, and topical spray. The tablets include 2.5, 5 and 10 mg forms; the solutions include 2% and 5% forms, and the foam and spray are both 5% concentration. The topical solutions are formulated with polyethylene glycol (PEG) to enhance absorption of minoxidil. The topical solution is often referred to as minoxidil topical solution (MTS) and the topical foam is known as minoxidil topical foam (MTF).
Upper Crust is an international chain of baguette restaurants concentrated along commuter routes. The outlets are commonplace in stations and terminals. There are branches at the central railway station in Oslo and Elkjøp Megastore Lørenskog, Norway. Since September 2008, there are also three units in Stockholm, Sweden – two at the central railway station and one at the nearby bus terminal, Cityterminalen. There is also one in the Gothenburg Central Station, and one in Euston Station, London. The company has started to expand into shopping centres, with a new store at Bridgend Designer Outlet, South Wales. There are also branches in airports, including Cairo Airport, Tromsø Airport, Trondheim Værnes Airport, Oslo Airport Gardermoen, Helsinki Airport, Toronto Airport, Sofia Vasil Levski Airport, George Bush Intercontinental Airport and Gran Canaria Airport. They were located in Australia too in the past, at places such as Circular Quay.
Keratotomies are a group of corneal procedures. Radial keratotomy is a refractive surgery procedure where the surgeon makes a spoke-like pattern of incisions into the cornea to modify its shape. This early surgical option for myopia has been largely superseded by PRK, LASIK and other similar laser procedures. Laser surgery is usually contraindicated in keratoconus and other corneal thinning conditions, as removal of corneal stromal tissue will further damage an already thin and weak cornea. For similar reasons, radial keratotomy has also generally not been used for people with keratoconus. However, more modern and keratoconus-specific variants, such as Mini asymmetric radial keratotomy (MARK) and Circular keratotomy (CK), have been found to be useful in keratoconus management, particularly when combined with Corneal cross-linking.
== Management == The main aim in the treatment of diabetic ketoacidosis is to replace the lost fluids and electrolytes while suppressing the high blood sugars and ketone production with insulin. Admission to an intensive care unit (ICU) or similar high-dependency area or ward for close observation may be necessary.
These are sympatholytic drugs that block the effects of adrenergic alpha receptors while having little or no effect on beta receptors. Drugs belonging to this group can have very different effects, however, depending on whether they primarily block alpha-1 receptors, alpha-2 receptors, or both. Alpha-2 receptors, as described elsewhere in this article, are frequently located on norepinephrine-releasing neurons themselves and have inhibitory effects on them; consequently, blockage of alpha-2 receptors usually results in an increase in norepinephrine release. Alpha-1 receptors are usually located on target cells and have excitatory effects on them; consequently, blockage of alpha-1 receptors usually results in blocking some of the effects of norepinephrine. Drugs such as phentolamine that act on both types of receptors can produce a complex combination of both effects. In most cases when the term "alpha blocker" is used without qualification, it refers to a selective alpha-1 antagonist. Selective alpha-1 blockers have a variety of uses. Since one of their effects is to inhibit the contraction of the smooth muscle in the prostate, they are often used to treat symptoms of benign prostatic hyperplasia. Alpha-blockers also likely help people pass their kidney stones. Their effects on the central nervous system make them useful for treating generalized anxiety disorder, panic disorder, and posttraumatic stress disorder. They may, however, have significant side effects, including a drop in blood pressure.
Sources: en.wikipedia.org
It mirrors the 44-residue form of human growth hormone-releasing hormone. A hexenoyl group on the N-terminal tyrosine distinguishes it from the unmodified hormone. The change is intended to improve resistance to enzymatic breakdown.
The N-terminal modification reduces cleavage by circulating peptidases, so the peptide persists longer than native GHRH. That persistence is the main rationale for the synthetic design. Comparative half-life values in humans are reported in regulatory review documents rather than in general reference literature.
Reductions in visceral adipose tissue have been measured in controlled studies of defined populations. Whether the effect generalizes to other groups and persists after treatment stops is less clear. Longer-term outcome data remain limited.
Lyophilized material is typically kept refrigerated and away from light in the sealed vial provided. Dissolved material is generally used within a limited period rather than stored long term.